PhRMA Seeks Regulatory Guidance On Primary Prevention Products
This article was originally published in The Pink Sheet Daily
Executive Summary
The trade association also hopes HHS will encourage reimbursement policies that support the effective delivery of prevention products to patients, PhRMA VP-Scientific & Regulatory Affairs Loew says.